EU eradication and monitoring programmes are co-funded to eliminate animal diseases and implement disease monitoring in EU countries. They are part of the EU Animal Health Strategy helping reach EU objectives in the field of animal and public health.
Eligible diseases for EU co-funding
EU countries are obliged to apply the Transmissible Spongiform Encephalopaties (TSE) and avian influenza programmes. EU co-funding covers national expenditure for the control and monitoring of certain animal diseases and zoonoses (Annex I - Decision 2009/470/EC) e.g.:
- Bovine tuberculosis
- Bovine brucellosis
- Ovine and caprine brucellosis (B. melitensis)
- Bluetongue in endemic or high risk areas
- African swine fever
- Swine vesicular disease
- Classical swine fever
- Avian influenza
- Transmissible spongiform encephalopathies (TSE)
- Salmonellosis (zoonotic salmonella)
Decision 2009/470/EC - expenditure in the veterinary field and procedures for co-funding eradication, control and monitoring programmes
By 30 April every year EU countries submit to the Commission the annual or multiannual programmes requesting an EU contribution for the following year
Decisions approving eradication programmes and reallocation
2013 - Decision 2012/761/EU
2012 and following years - Decision 2011/807/EU amended by Decision 2012/147/EU
2011 and following years - Decision 2010/712/EU amended by Decision 2011/862/EU
2010 and following years - Decision 2009/883/EC amended by Decision 2010/732/EU
2009 and following years - Decision 2008/897/EC amended by Decision 2009/858/EC
Procedures for co-financing
EU countries' programmes should cover:
- The epidemiological situation of the disease before the programme begins;
- The geographical and administrative range where the programme will apply;
- Duration, measures and objective. Programmes can be multiannual.
- Estimated costs and benefits.
The Commission considers programmes from the veterinary and financial angle and checks compliance with EU criteria (Decision 2008/341/EC)
Programme measures should be effective and achieve rapid eradication, control and monitoring of the diseases and zoonoses concerned.
Submission of eradication and control programmes
Standard requirements for applications are listed in the Annexes - Decision 2008/425/EC, amended by Decision 2012/282/EC
- Bovine tuberculosis;
- Bovine brucellosis;
- Ovine and caprine brucellosis;
- Classical swine fever;
- African swine fever;
- Swine vesicular disease;
- Transmissible Spongiform Encephalopaties (TSEs)
Every year, the Commission draws a list of the programmes that qualify for co-financing in a decision with the proposed amount for each. Diseases with public health and economic impacts receive the greatest weighting.
For each programme, EU countries submit:
- Intermediate technical and financial reports;
- By 30 April each year, an annual technical report assessing the results and expenditure of the previous year.
Reporting requirements - Decision 2008/940/EC
The Commission evaluates annually if its funds are used adequately. Final payments depend on the satisfactory evaluation of the programmes' implementation.
EU countries present the results of their programmes to the Standing Committee on the Food Chain and Animal Health (SCoFCAH).
EU countries should update their actual and likely use of EU funds towards the end of the 1st semester. Those with eligible expenditure above the allowed amounts must justify the difference.
The Commission considers reallocating between programmes to ensure optimal use of the funds. It amends the annual financial decision in the reallocation Decision at the end of the year.
The reallocation Decision endorses modified programmes if for epidemiological reasons their scope has changed e.g. area for vaccination, targets for testing or more slaughter animals.
The task force on the eradication of animal diseases monitors disease eradication in EU countries to improve the cost-benefit ratio of eradication programmes co-funded by the EU. Members are EU countries and Commission representatives. It meets annually in Brussels, chaired by the Commission.
Its members are EU countries and Commission representatives. It meets annually in Brussels, chaired by the Commission.
Report of the Plenary Task Force 2012
Report of the Plenary Task Force 2011
Report of the Plenary Task Force 2010
Subgroups give tailored technical assistance to EU countries for some diseases:
- bovine tuberculosis
- bovine brucellosis
- sheep and goat brucellosis (merged with bovine brucellosis since 2012)
- classical swine fever
Members are EU countries representatives with an approved programme for the respective disease, other concerned EU countries, independent experts and the Commission.
Meetings are held in a country with an approved eradication programme and in areas with particular problems. This allows discussions with local vets and possible visits to farms, laboratories, vet services, etc.
Since 2010, the scope of subgroups extends to relevant non-EU countries given the trans-boundary nature of the disease e.g. classical swine fever in Serbia and rabies in Kaliningrade.
Bovine tuberculosis subgroup
Report - Spain, October 2012
Report - The United Kingdom, March 2012
Report - Dublin, Ireland, November 2011
Report - Zagreb, Croatia, July 2011
Report - Brescia, Italy, June 2010
Report - Idanha-a-Nova, Portugal, April 2010
Working Document on Eradication of Bovine Tuberculosis in the EU accepted by the Bovine tuberculosis subgroup of the Task Force on monitoring animal disease eradication (SANCO/10067/2013)
Working Document on Eradication of Bovine, Sheep and Goats Brucellosis in the EU accepted by the “Bovine” and “Sheep and Goats” Brucellosis subgroups of the Task Force on monitoring animal disease eradication (SANCO/6095/2009)
Report - Halkidiki, Greece, 14-15 June 2012
Report - Belfast, Northern Ireland, December 2011
Report - Santander, Spain, October 2010
Report - Valladolid, Spain, June 2009
Report - Warsaw, Poland, December 2012
Report - Zagreb, Croatia, November 2012
Report - Plovdiv, Bulgaria, March 2011
Report - Kaliningrade, Russia, April 2011
Report - Tartu, Estonia, November 2010
Report - Vilnius, Lithuania, October 2009
Report - Tomar, Portugal, May - June 2012
Report - Nicosia, Cyprus, October 2011
Report - Brussels, Belgium, May 2010
Report - Warszaw, Poland, March 2009
Classical swine fever subgroup
Report - Belgrade, Serbia April 2011 - Agenda - Annexes
Report - Budapest, Hungary December 2010 - Annexes
Report - Bucharest, Romania, November 2009
Report - Hannover, Germany, April 2009
Indicators for the evaluation of the implementation of the programmes
The Commission with the support of the experts of the different task force subgroups have drafted this document listing some quantifiable and objective measurements (indicators) to evaluate the implementation and management of eradication, control or monitoring programmes, the effectiveness of the measures implemented and to measure progress or the deficiency in a specific area.
The indicators are disease specific and divided in two main categories:
- Activities (AI): to verify if the measures planned in the approved programmes are implemented as foreseen
- Progress (PI): to measure the progress towards achievement of the objectives of the programme (eradication/control/monitoring) in relation to the evolution of the disease in previous years.
Indicators for animal disease eradication, control and monitoring programmes- SANCO/12915/2012
The summary report on the outcome of the EU co-financed animal disease eradication and monitoring programmes (PERIOD 2007-2011)
Comes to update the report for the period for 2005-2009.
In the framework of article 41 of Council Decision Decision 2009/470/EC a report from the Commission to the European Parliament and to the Council on the animal health situation and cost-effectiveness of the implementation of the EU co-financed veterinary programmes will be soon available aiming, inter-alia, at identifying the strengths and weaknesses in policy-related measures' development, gaps in implementation, as well as recommendations for better prioritisation, reduction of administrative burden and the best cost-effective use of the investments in this area.